Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC

Published Date: 13 Sep 2024

Two-trial analysis shows about a 40% decreased risk of disease recurrence or death

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer death rates higher for children in neighborhoods with persistent poverty, study finds

2.

Novel analysis identifies markers that may predict failure of metastatic prostate cancer treatment

3.

Asian Women With Breast Cancer Outlive White Peers

4.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

5.

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot